• Facebook
  • X
  • Instagram
MYELOMA360
  • Home
  • MYInsights
  • MYBoard
  • Strategy & Consulting
Select Page

B-cell maturation antigen-based therapies post-talquetamab in relapsed or refractory multiple myeloma

by | Jun 19, 2024 | Publications

EJHaem. 2024 Apr 16;5(3):554-559. doi: 10.1002/jha2.896. eCollection 2024 Jun. ABSTRACT Talquetamab recently received approval for relapsed refractory multiple myeloma. However, there is currently no available data on how patients perform with BCMA based agents after...

Daratumumab improved severe neutrophilia and paraneoplastic bone marrow fibrosis in granulocyte-colony stimulating factor-producing multiple myeloma

by | Jun 19, 2024 | Publications

EJHaem. 2024 May 8;5(3):638-641. doi: 10.1002/jha2.901. eCollection 2024 Jun. NO ABSTRACT PMID:38895077 | PMC:PMC11182393 | DOI:10.1002/jha2.901

Aberrant CD4 expression in plasmablastic transformation of multiple myeloma

by | Jun 19, 2024 | Publications

EJHaem. 2024 May 21;5(3):629-630. doi: 10.1002/jha2.935. eCollection 2024 Jun. NO ABSTRACT PMID:38895083 | PMC:PMC11182412 | DOI:10.1002/jha2.935

The choice of serum-free light chain analysis method could potentially have clinical consequences for myeloma patients

by | Jun 19, 2024 | Publications

EJHaem. 2024 Apr 9;5(3):455-461. doi: 10.1002/jha2.886. eCollection 2024 Jun. ABSTRACT Multiple myeloma (MM) is a disease, that at times poses diagnostic and monitoring challenges. Over the last decades laboratory methods have been expanded with serum free light chain...

Multiple myeloma, IL6, and risk of schizophrenia: A Mendelian randomization, transcriptome, and Bayesian colocalization study

by | Jun 19, 2024 | Publications

EJHaem. 2024 Apr 11;5(3):462-473. doi: 10.1002/jha2.890. eCollection 2024 Jun. ABSTRACT Numerous clinical studies speculated the association between multiple myeloma (MM) and inflammatory diseases; however, there is limited validation of these claims via establishing...

Hallmarks of tumor-experienced T cells are absent in multiple myeloma patients from diagnosis through maintenance therapy

by | Jun 19, 2024 | Publications

bioRxiv [Preprint]. 2024 Jun 4:2024.06.03.597178. doi: 10.1101/2024.06.03.597178. ABSTRACT Dysregulation of the bone marrow (BM) niche in multiple myeloma (MM) alters the composition and state of resident immune cells, potentially impeding anti-tumor immunity. One...
« Older Entries
Next Entries »

Recent Content

  • Sex-specific dysregulation of exosomal non-coding RNAs drives multiple myeloma progression
  • 35 years of academic trials focusing on high-dose therapy and autologous stem cell transplantation: the Intergroupe Francophone du Myélome (IFM) experience
  • Hypoalbuminemia: a new risk factor for progression in patients with monoclonal gammopathy of uncertain significance
  • Comparative efficacy and safety of BCMA-targeted CAR T cells and BiTEs in relapsed/refractory multiple myeloma: a meta-analysis of interventional and real-world studies
  • (no title)
  • FDA OK’s belantamab mafodotin-blmf for multiple myeloma
  • Using RNA-seq for detecting MRD in multiple myeloma: high sensitivity and prognostic value
  • (no title)
  • (no title)
  • (no title)
  • Facebook
  • X
  • Instagram
©2016-2025 MYELOMA360 & Connect BioMed
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
SettingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT